banda transcan 2 2016ul

The Joint Transnational Calls (JTC) in translational cancer research launched until now are 6.

 

Three of them were launched and implemented under the previous TRANSCAN project:

 

JTC 2011  launched on December 2011 on: "Validation of biomarkers for personalised cancer medicine", 10 projects funded

JTC 2012  launched on December 2012 on: “Translational research on primary and secondary prevention of cancer”, 10 projects funded

JTC 2013  launched on December 2013 on: "Translational research on tertiary prevention in cancer patients", 10 projects funded

 

The ongoing TRANSCAN-2 project has launched the following calls:

 

JTC 2014 (co-funded by the European Commission)  launched on January 2015 on: "Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy", 16 projects funded

JTC 2015  launched on December 2015 on: “Immunology and immunotherapy of cancer: strengthening the translational aspects”, 7 projects funded

JTC 2016 launched on December 2016 on: "Minimally and non-invasive methods for early detection and/or progression of cancer", 14 projects selected for funding

JTC 2017 pre-announced on 6 October 2017, will be launched on December 2017.


TRANSCAN-2 News


PRE-ANNOUNCEMENT

The Fourth Joint Transnational Call 2017 (JTC 2017)

will be launched on December 5th, 2017

on: Translational Research on Rare Cancers

The list of participant funding organizations has been updated on November 21st

(FCT - Portugal has joined the call)

visit the page


JTC 2016

on: “Minimally and non-invasive methods for early detection and/or progression of cancer"

14 projects selected for funding 

visit the page


 

Newsletters

Newsletter 3, September 2017

Newsletter 2, April 2017

Newsletter 1, December 2016

 

To subscribe to TRANSCAN-2 newsletter mailing list please send an email to: This email address is being protected from spambots. You need JavaScript enabled to view it.

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.

Cookie consent script